Shire plc (ADR)

NASDAQ: SHPG
$179.20
+$0.00 (+0.0%)
Closing price January 8, 2019
Shire made waves Tuesday morning following a key FDA approval of its eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.
It now appears that the Federal Reserve may wait until July to lift rates. Either way, the rates will be raised, and it makes good sense now to look at the top value ideas.
Stocks were indicated higher on Thursday, after gains on Tuesday and Wednesday were handy. Oil also crossed back above the $50 barrier again for the first time since October 2015. The notion of...
New research from Jefferies highlights this week's top growth stock picks, and there is a clear bias for some top biotech and pharmaceutical stocks — and with good reason. They are cheap and have...
Baxalta is scheduled to report fourth-quarter and full-year results before markets open on Tuesday.
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
Stocks got a big boost on news that Janet Yellen is talking down the Federal Reserve’s desire to hike interest rates no matter what. Investors in 2016 have used rallies a chance to sell, with a...
Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.
Stocks tried to stabilize on Monday, and Tuesday’s early indications were for Dow and S&P 500 futures to be up almost 1%. Last week’s sell-off may have been the worst opening week for...
All these Cowen picks offer compelling values for 2016, and all have backed up enough in price for investors to get an outstanding entry point.
Shire and Dyax announced Monday morning that former will acquire latter for almost $6 billion.
Source: ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the Biotechnology Index is up only 0.3%, pretty much breakeven. While the...
In a new report, SunTrust Robinson Humphrey features stock picks that are designed to help clients "catch up" to their benchmarks.
Monday’s top analyst upgrades, downgrades and initiations include CyberArk Software, Goldman Sachs, Lululemon Athletica, Micron Technology, Nike, Nokia and SanDisk.